{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:04:52Z","timestamp":1786982692110,"version":"build-2736575974"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,4,27]],"date-time":"2024-04-27T00:00:00Z","timestamp":1714176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,27]],"date-time":"2024-04-27T00:00:00Z","timestamp":1714176000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001777","name":"The University of Wollongong","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001777","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Nutr Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose of Review<\/jats:title>\n                    <jats:p>Metabolic comorbidities such as obesity, diabetes, hypertension, and dyslipidemia are common to multiple sclerosis (MS) and are associated with negative outcomes of the disease. Dietary intervention has the potential to improve MS co-morbidities; thus, it is a high priority for people living\u00a0with MS to self-manage their disease. The present review aimed to summarize the recent evidence on the impacts of combining dietary modification with nutrition education and counseling on managing metabolic comorbidity markers in MS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent Findings<\/jats:title>\n                    <jats:p>Evidence suggests important roles for tailored dietary change strategies and nutrition education and counseling in managing metabolic comorbidities\u00a0for MS. There is also indirect evidence suggesting a relationship between dietary fiber, the gut microbiome, and improved metabolic markers in MS, highlighting the need for more research in this area. For people living\u00a0with MS, addressing both barriers and facilitators to dietary changes through behavior change techniques can help them achieve sustainable and tailored dietary behavior changes. This\u00a0will\u00a0support person-centered care, ultimately improving metabolic comorbidity outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>Metabolic comorbidities in MS are considered modifiable diseases that can be prevented and managed by changes in dietary behavior. However, the impact of targeted dietary interventions on mitigating MS-related metabolic comorbidities remains inadequately explored. Therefore, this review has provided insights into recommendations to inform future best practices in MS. Further well-designed studies based on tailored dietary strategies applying behavior change theories are needed to address the underlying determinants of dietary practice in this population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s13668-024-00538-8","type":"journal-article","created":{"date-parts":[[2024,4,27]],"date-time":"2024-04-27T03:02:26Z","timestamp":1714186946000},"page":"106-112","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Dietary Modification Combined with Nutrition Education and Counseling for Metabolic Comorbidities in Multiple Sclerosis: Implications for Clinical Practice and Research"],"prefix":"10.1007","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-1197-0676","authenticated-orcid":false,"given":"Shoroog","family":"Allogmanny","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1971-173X","authenticated-orcid":false,"given":"Yasmine","family":"Probst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,27]]},"reference":[{"issue":"8","key":"538_CR1","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1001\/jama.2020.26858","volume":"325","author":"MP McGinley","year":"2021","unstructured":"McGinley MP, Goldschmidt CH, Rae-Grant AD. Diagnosis and treatment of multiple sclerosis: a review. JAMA. 2021;325(8):765\u201379. https:\/\/doi.org\/10.1001\/jama.2020.26858.","journal-title":"JAMA"},{"key":"538_CR2","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s40120-021-00239-2","volume":"10","author":"L Lakin","year":"2021","unstructured":"Lakin L, Davis BE, Binns CC, Currie KM, Rensel MR. Comprehensive approach to management of multiple sclerosis: addressing invisible symptoms\u2014a narrative review. Neurology and therapy. 2021;10:75\u201398. https:\/\/doi.org\/10.1007\/s40120-021-00239-2.","journal-title":"Neurology and therapy"},{"issue":"3","key":"538_CR3","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1093\/brain\/116.3.681","volume":"116","author":"JW Prineas","year":"1993","unstructured":"Prineas JW, Barnard RO, Revesz T, Kwon EE, Sharer L, Cho E-S. Multiple sclerosis: pathology of recurrent lesions. Brain. 1993;116(3):681\u201393. https:\/\/doi.org\/10.1093\/brain\/116.3.681.","journal-title":"Brain"},{"issue":"11","key":"538_CR4","doi-asserted-by":"publisher","first-page":"4066","DOI":"10.1007\/s00415-020-10107-y","volume":"268","author":"L Hauer","year":"2021","unstructured":"\u2022 Hauer L, Perneczky J, Sellner J. A global view of comorbidity in multiple sclerosis: a systematic review with a focus on regional differences, methodology, and clinical implications. J Neurol. 2021;268(11):4066\u201377. https:\/\/doi.org\/10.1007\/s00415-020-10107-y. A global systematic review shows the worldwide prevalence and patterns of comorbid conditions, including metabolic in multiple sclerosis.","journal-title":"J Neurol"},{"issue":"1","key":"538_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2377-14-128","volume":"14","author":"RJ Simpson","year":"2014","unstructured":"Simpson RJ, McLean G, Guthrie B, Mair F, Mercer SW. Physical and mental health comorbidity is common in people with multiple sclerosis: nationally representative cross-sectional population database analysis. BMC Neurol. 2014;14(1):1\u20138. https:\/\/doi.org\/10.1186\/1471-2377-14-128.","journal-title":"BMC Neurol"},{"issue":"8","key":"538_CR6","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.jclinepi.2005.11.013","volume":"59","author":"SF Hall","year":"2006","unstructured":"Hall SF. A user\u2019s guide to selecting a comorbidity index for clinical research. J Clin Epidemiol. 2006;59(8):849\u201355. https:\/\/doi.org\/10.1016\/j.jclinepi.2005.11.013.","journal-title":"J Clin Epidemiol"},{"key":"538_CR7","doi-asserted-by":"publisher","first-page":"102565","DOI":"10.1016\/j.msard.2020.102565","volume":"46","author":"E Ciampi","year":"2020","unstructured":"Ciampi E, Uribe-San-Martin R, Soler B, Molnar K, Reyes D, Keller K, et al. Prevalence of comorbidities in multiple sclerosis and impact on physical disability according to disease phenotypes. Mult Scler Related Disorders. 2020;46.","journal-title":"Mult Scler Related Disorders"},{"issue":"1","key":"538_CR8","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/ane.13516","volume":"145","author":"G Maric","year":"2022","unstructured":"Maric G, Pekmezovic T, Tamas O, Veselinovic N, Jovanovic A, Lalic K, et al. Impact of comorbidities on the disability progression in multiple sclerosis. Acta Neurol Scand. 2022;145(1):24\u20139. https:\/\/doi.org\/10.1111\/ane.13516.","journal-title":"Acta Neurol Scand"},{"key":"538_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2022.105788","volume":"142","author":"M Waliszewska-Pros\u00f3\u0142","year":"2022","unstructured":"Waliszewska-Pros\u00f3\u0142 M, Nowakowska-Kotas M, Misiak B, Chojdak-\u0141ukasiewicz J, Budrewicz S, Pokryszko-Dragan A. Allostatic load index in patients with multiple sclerosis: a case-control study. Psychoneuroendocrinology. 2022;142: 105788. https:\/\/doi.org\/10.1016\/j.psyneuen.2022.105788.","journal-title":"Psychoneuroendocrinology"},{"key":"538_CR10","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1007\/s11910-012-0293-4","volume":"12","author":"S Overs","year":"2012","unstructured":"Overs S, Hughes CM, Haselkorn JK, Turner AP. Modifiable comorbidities and disability in multiple sclerosis. Curr Neurol Neurosci Rep. 2012;12:610\u20137. https:\/\/doi.org\/10.1007\/s11910-012-0293-4.","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"2","key":"538_CR11","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1212\/01.wnl.0000333252.78173.5f","volume":"72","author":"RA Marrie","year":"2009","unstructured":"Marrie RA, Horwitz R, Cutter G, Tyry T, Campagnolo D, Vollmer T. Comorbidity delays diagnosis and increases disability at diagnosis in MS. Neurology. 2009;72(2):117\u201324. https:\/\/doi.org\/10.1212\/01.wnl.0000333252.78173.5f.","journal-title":"Neurology"},{"key":"538_CR12","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/s00415-020-10192-z","volume":"268","author":"LMP Lo","year":"2021","unstructured":"Lo LMP, Taylor BV, Winzenberg T, Palmer AJ, Blizzard L, van der Mei I. Comorbidities contribute substantially to the severity of common multiple sclerosis symptoms. J Neurol. 2021;268:559\u201368. https:\/\/doi.org\/10.1007\/s00415-020-10192-z.","journal-title":"J Neurol"},{"key":"538_CR13","doi-asserted-by":"publisher","first-page":"851","DOI":"10.3389\/fneur.2020.00851","volume":"11","author":"M Magyari","year":"2020","unstructured":"Magyari M, Sorensen PS. Comorbidity in multiple sclerosis. Front Neurol. 2020;11:851. https:\/\/doi.org\/10.3389\/fneur.2020.00851.","journal-title":"Front Neurol"},{"issue":"3","key":"538_CR14","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1007\/s10072-022-06517-7","volume":"44","author":"M Ponzio","year":"2023","unstructured":"Ponzio M, Monti MC, Mallucci G, Borrelli P, Fusco S, Tacchino A, et al. The economic impact of comorbidity in multiple sclerosis. Neurol Sci. 2023;44(3):999\u20131008. https:\/\/doi.org\/10.1007\/s10072-022-06517-7.","journal-title":"Neurol Sci"},{"issue":"12","key":"538_CR15","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1177\/1352458520984746","volume":"27","author":"KC Fitzgerald","year":"2021","unstructured":"Fitzgerald KC, Damian A, Conway D, Mowry EM. Vascular comorbidity is associated with lower brain volumes and lower neuroperformance in a large multiple sclerosis cohort. Mult Scler J. 2021;27(12):1914\u201323. https:\/\/doi.org\/10.1177\/1352458520984746.","journal-title":"Mult Scler J"},{"key":"538_CR16","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1684\/ecn.2018.0415","volume":"29","author":"J Karczewski","year":"2018","unstructured":"Karczewski J, \u015aledzi\u0144ska E, Baturo A, Jo\u0144czyk I, Maleszko A, Samborski P, et al. Obesity and inflammation European cytokine network. 2018;29:83\u201394. https:\/\/doi.org\/10.1684\/ecn.2018.0415.","journal-title":"Obesity and inflammation European cytokine network"},{"issue":"6","key":"538_CR17","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/nrneurol.2017.33","volume":"13","author":"RA Marrie","year":"2017","unstructured":"Marrie RA. Comorbidity in multiple sclerosis: implications for patient care. Nat Rev Neurol. 2017;13(6):375\u201382. https:\/\/doi.org\/10.1038\/nrneurol.2017.33.","journal-title":"Nat Rev Neurol"},{"issue":"24","key":"538_CR18","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1212\/WNL.0000000000004716","volume":"89","author":"K Kowalec","year":"2017","unstructured":"Kowalec K, McKay KA, Patten SB, Fisk JD, Evans C, Tremlett H, et al. Comorbidity increases the risk of relapse in multiple sclerosis: a prospective study. Neurology. 2017;89(24):2455\u201361. https:\/\/doi.org\/10.1212\/WNL.0000000000004716.","journal-title":"Neurology"},{"issue":"3","key":"538_CR19","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1111\/j.1600-0404.2011.01526.x","volume":"125","author":"RA Marrie","year":"2012","unstructured":"Marrie RA, Horwitz R, Cutter G, Tyry T. Cumulative impact of comorbidity on quality of life in MS. Acta Neurol Scand. 2012;125(3):180\u20136. https:\/\/doi.org\/10.1111\/j.1600-0404.2011.01526.x.","journal-title":"Acta Neurol Scand"},{"issue":"4","key":"538_CR20","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1161\/CIRCULATIONAHA.117.032047","volume":"138","author":"Y Li","year":"2018","unstructured":"Li Y, Pan A, Wang DD, Liu X, Dhana K, Franco OH, et al. Impact of healthy lifestyle factors on life expectancies in the US population. Circulation. 2018;138(4):345\u201355. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.117.032047.","journal-title":"Circulation"},{"issue":"2","key":"538_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0148573","volume":"11","author":"CH Marck","year":"2016","unstructured":"Marck CH, Neate SL, Taylor KL, Weiland TJ, Jelinek GA. Prevalence of comorbidities, overweight and obesity in an international sample of people with multiple sclerosis and associations with modifiable lifestyle factors. PLoS ONE. 2016;11(2): e0148573. https:\/\/doi.org\/10.1371\/journal.pone.0148573.","journal-title":"PLoS ONE"},{"issue":"1","key":"538_CR22","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1071\/hc13059","volume":"5","author":"L Ball","year":"2013","unstructured":"Ball L, Johnson C, Desbrow B, Leveritt M. General practitioners can offer effective nutrition care to patients with lifestyle-related chronic disease. J Prim Health Care. 2013;5(1):59\u201369. https:\/\/doi.org\/10.1071\/hc13059.","journal-title":"J Prim Health Care"},{"key":"538_CR23","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1007\/s13311-017-0563-6","volume":"14","author":"BP Moss","year":"2017","unstructured":"Moss BP, Rensel MR, Hersh CM. Wellness and the role of comorbidities in multiple sclerosis. Neurotherapeutics. 2017;14:999\u20131017. https:\/\/doi.org\/10.1007\/s13311-017-0563-6.","journal-title":"Neurotherapeutics"},{"issue":"4","key":"538_CR24","doi-asserted-by":"publisher","first-page":"209","DOI":"10.31128\/AJGP-09-21-6179","volume":"51","author":"Y Probst","year":"2022","unstructured":"Probst Y, Guan V, Van Der Walt A, Rath LM, Bonney A, Kent J. Patient self-management and empowerment for multiple sclerosis: the implications of dietary lifestyle management for primary care. Aus J Gen Pract. 2022;51(4):209\u201312. https:\/\/doi.org\/10.31128\/AJGP-09-21-6179.","journal-title":"Aus J Gen Pract"},{"issue":"10","key":"538_CR25","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1038\/s41430-021-00864-y","volume":"75","author":"CH Marck","year":"2021","unstructured":"Marck CH, Probst Y, Chen J, Taylor B, van der Mei I. Dietary patterns and associations with health outcomes in Australian people with multiple sclerosis. Eur J Clin Nutr. 2021;75(10):1506\u201314. https:\/\/doi.org\/10.1038\/s41430-021-00864-y.","journal-title":"Eur J Clin Nutr"},{"issue":"3","key":"538_CR26","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1111\/hex.13226","volume":"24","author":"RD Russell","year":"2021","unstructured":"Russell RD, Black LJ, Begley A. Navigating dietary advice for multiple sclerosis. Health Expect. 2021;24(3):853\u201362. https:\/\/doi.org\/10.1111\/hex.13226.","journal-title":"Health Expect"},{"issue":"6","key":"538_CR27","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1080\/1028415X.2017.1303016","volume":"21","author":"S Esposito","year":"2018","unstructured":"Esposito S, Bonavita S, Sparaco M, Gallo A, Tedeschi G. The role of diet in multiple sclerosis: a review. Nutr Neurosci. 2018;21(6):377\u201390. https:\/\/doi.org\/10.1080\/1028415X.2017.1303016.","journal-title":"Nutr Neurosci"},{"key":"538_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2019.101393","volume":"36","author":"E Evans","year":"2019","unstructured":"Evans E, Levasseur V, Cross AH, Piccio L. An overview of the current state of evidence for the role of specific diets in multiple sclerosis. Multiple Sclerosis and Related Disorders. 2019;36: 101393. https:\/\/doi.org\/10.1016\/j.msard.2019.101393.","journal-title":"Multiple Sclerosis and Related Disorders"},{"key":"538_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11136-023-03361-w","volume":"32","author":"H Kirkland","year":"2023","unstructured":"Kirkland H, Campbell J, Reece J, Nag N, Probst Y, Neate S, et al. Higher diet quality is associated with short and long-term benefits on SF-6D health state utilities: a 5-year cohort study in an international sample of people with multiple sclerosis. Qual Life Res. 2023;32:1\u201314. https:\/\/doi.org\/10.1007\/s11136-023-03361-w.","journal-title":"Qual Life Res"},{"issue":"6","key":"538_CR30","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/S2213-8587(19)30093-2","volume":"7","author":"Q Gong","year":"2019","unstructured":"Gong Q, Zhang P, Wang J, Ma J, An Y, Chen Y, et al. Morbidity and mortality after lifestyle intervention for people with impaired glucose tolerance: 30-year results of the Da Qing Diabetes Prevention Outcome Study. Lancet Diabetes Endocrinol. 2019;7(6):452\u201361. https:\/\/doi.org\/10.1016\/S2213-8587(19)30093-2.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"7","key":"538_CR31","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.3390\/nu13072179","volume":"13","author":"X Gao","year":"2021","unstructured":"Gao X, Tian Z, Zhao D, Li K, Zhao Y, Xu L, et al. Associations between adherence to four a priori dietary indexes and cardiometabolic risk factors among hyperlipidemic patients. Nutrients. 2021;13(7):2179. https:\/\/doi.org\/10.3390\/nu13072179.","journal-title":"Nutrients"},{"issue":"9","key":"538_CR32","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.3390\/nu14091927","volume":"14","author":"E Suliga","year":"2022","unstructured":"\u2022 Suliga E, Brola W, Soba\u015b K, Cie\u015bla E, Jasi\u0144ska E, Go\u0142uch K, et al. Dietary patterns and metabolic disorders in Polish adults with multiple sclerosis. Nutrients. 2022;14(9):1927. https:\/\/doi.org\/10.3390\/nu14091927. This study analyzed the dietary patterns of people with multiple sclerosis, and it found that an unhealthy dietary pattern was associated with the presence of some metabolic risk factors, such as abdominal obesity and low HDL-cholesterol levels.","journal-title":"Nutrients"},{"issue":"4","key":"538_CR33","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1212\/cpj.0000000000001045","volume":"11","author":"TL Vollmer","year":"2021","unstructured":"Vollmer TL, Nair KV, Williams IM, Alvarez E. Multiple sclerosis phenotypes as a continuum: the role of neurologic reserve. Neurol Clin Pract. 2021;11(4):342\u201351. https:\/\/doi.org\/10.1212\/cpj.0000000000001045.","journal-title":"Neurol Clin Pract"},{"issue":"2","key":"538_CR34","first-page":"22","volume":"5","author":"V Dorothy","year":"2022","unstructured":"Dorothy V. Dietary patterns and metabolic disorders in multiple sclerosis. Neurosurg J. 2022;5(2):22\u20133.","journal-title":"Neurosurg J"},{"issue":"2","key":"538_CR35","doi-asserted-by":"publisher","first-page":"459","DOI":"10.3390\/nu11020459","volume":"11","author":"O Ojo","year":"2019","unstructured":"Ojo O. Nutrition and chronic conditions. Nutrients. 2019;11(2):459. https:\/\/doi.org\/10.3390\/nu11020459.","journal-title":"Nutrients"},{"issue":"12","key":"538_CR36","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1016\/j.jand.2017.06.364","volume":"117","author":"LJ Mitchell","year":"2017","unstructured":"Mitchell LJ, Ball LE, Ross LJ, Barnes KA, Williams LT. Effectiveness of dietetic consultations in primary health care: a systematic review of randomized controlled trials. J Acad Nutr Diet. 2017;117(12):1941\u201362. https:\/\/doi.org\/10.1016\/j.jand.2017.06.364.","journal-title":"J Acad Nutr Diet"},{"issue":"8","key":"538_CR37","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1093\/abm\/kay078","volume":"53","author":"RN Carey","year":"2019","unstructured":"Carey RN, Connell LE, Johnston M, Rothman AJ, De Bruin M, Kelly MP, et al. Behavior change techniques and their mechanisms of action: a synthesis of links described in published intervention literature. Ann Behav Med. 2019;53(8):693\u2013707. https:\/\/doi.org\/10.1093\/abm\/kay078.","journal-title":"Ann Behav Med"},{"issue":"12","key":"538_CR38","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1097\/PHM.0b013e31829e780e","volume":"92","author":"JH Rimmer","year":"2013","unstructured":"Rimmer JH, Wang E, Pellegrini CA, Lullo C, Gerber BS. Telehealth weight management intervention for adults with physical disabilities: a randomized controlled trial. Am J Phys Med Rehabil. 2013;92(12):1084\u201394. https:\/\/doi.org\/10.1097\/PHM.0b013e31829e780e.","journal-title":"Am J Phys Med Rehabil"},{"issue":"1","key":"538_CR39","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13690-022-01013-y","volume":"81","author":"Z Afifi","year":"2023","unstructured":"\u2022\u2022 Afifi Z, Hassan A, Abdelrahman N, El Sayed A, Salem M. Impact of nutrition counseling on anthropometry and dietary intake of multiple sclerosis patients at Kasr Alainy Multiple Sclerosis Unit, Cairo, Egypt 2019\u20132020: randomized controlled clinical trial. Archives of Public Health. 2023;81(1):11. https:\/\/doi.org\/10.1186\/s13690-022-01013-y. This randomized controlled clinical trial examined the relationship between nutrition counselling on a healthy diet and body parameters in people with multiple sclerosis. It depicts how healthy dietary modification combined with nutrition counselling can significantly improve anthropometric measurements.","journal-title":"Archives of Public Health"},{"key":"538_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2020.102504","volume":"46","author":"BC Wingo","year":"2020","unstructured":"\u2022\u2022 Wingo BC, Rinker JR, Goss AM, Green K, Wicks V, Cutter GR, et al. Feasibility of improving dietary quality using a telehealth lifestyle intervention for adults with multiple sclerosis. Mult Scler Relat Disord. 2020;46: 102504. https:\/\/doi.org\/10.1016\/j.msard.2020.102504. This interventional study highlights the effectiveness of healthy behavioral dietary education delivered through telehealth in improving diet quality and reducing cardiometabolic risk in people with multiple sclerosis.","journal-title":"Mult Scler Relat Disord"},{"issue":"1","key":"538_CR41","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3390\/dietetics1010004","volume":"1","author":"P Papandreou","year":"2022","unstructured":"\u2022\u2022 Papandreou P, Gioxari A, Daskalou E, Vasilopoulou A, Skouroliakou M. Personalized nutritional intervention to improve Mediterranean diet adherence in female patients with multiple sclerosis: a randomized controlled study. Dietetics. 2022;1(1):25\u201338. https:\/\/doi.org\/10.3390\/dietetics1010004. This randomized controlled clinical trial showed the significant effect of dietitian counseling and individualized dietary interventions on improving body composition measurements and serum glucose in people with multiple sclerosis.","journal-title":"Dietetics"},{"issue":"5","key":"538_CR42","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1161\/CIRCRESAHA.118.313348","volume":"124","author":"MA Mart\u00ednez-Gonz\u00e1lez","year":"2019","unstructured":"Mart\u00ednez-Gonz\u00e1lez MA, Gea A, Ruiz-Canela M. The Mediterranean diet and cardiovascular health: a critical review. Circ Res. 2019;124(5):779\u201398. https:\/\/doi.org\/10.1161\/CIRCRESAHA.118.313348.","journal-title":"Circ Res"},{"key":"538_CR43","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.msard.2016.07.001","volume":"9","author":"V Yadav","year":"2016","unstructured":"Yadav V, Marracci G, Kim E, Spain R, Cameron M, Overs S, et al. Low-fat, plant-based diet in multiple sclerosis: a randomized controlled trial. Mult Scler Relat Disord. 2016;9:80\u201390. https:\/\/doi.org\/10.1016\/j.msard.2016.07.001.","journal-title":"Mult Scler Relat Disord"},{"key":"538_CR44","doi-asserted-by":"publisher","DOI":"10.1590\/1678-9865202235e220153","author":"Z Uzdil","year":"2022","unstructured":"Uzdil Z, T\u00fcrker PF, Terzi M. Effects of nutrition education given to persons with multiple sclerosis and their families on diet quality and anthropometric and biochemical measurements. Revista de Nutri\u00e7\u00e3o. 2022. https:\/\/doi.org\/10.1590\/1678-9865202235e220153.","journal-title":"Revista de Nutri\u00e7\u00e3o"},{"key":"538_CR45","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.breast.2021.08.008","volume":"60","author":"I Trestini","year":"2021","unstructured":"Trestini I, Sperduti I, Caldart A, Bonaiuto C, Fiorio E, Parolin V, et al. Evidence-based tailored nutrition educational intervention improves adherence to dietary guidelines, anthropometric measures and serum metabolic biomarkers in early-stage breast cancer patients: a prospective interventional study. The Breast. 2021;60:6\u201314. https:\/\/doi.org\/10.1016\/j.breast.2021.08.008.","journal-title":"The Breast"},{"key":"538_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2023.101737","volume":"66","author":"L Xie","year":"2023","unstructured":"Xie L, Alam MJ, Marques FZ, Mackay CR. A major mechanism for immunomodulation: dietary fibres and acid metabolites. Semin Immunol. 2023;66: 101737. https:\/\/doi.org\/10.1016\/j.smim.2023.101737.","journal-title":"Semin Immunol"},{"issue":"5","key":"538_CR47","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.3390\/nu13051655","volume":"13","author":"P Cronin","year":"2021","unstructured":"Cronin P, Joyce SA, O\u2019Toole PW, O\u2019Connor EM. Dietary fibre modulates the gut microbiota. Nutrients. 2021;13(5):1655. https:\/\/doi.org\/10.3390\/nu13051655.","journal-title":"Nutrients"},{"key":"538_CR48","doi-asserted-by":"publisher","DOI":"10.1017\/S095442241700004X","author":"AM Stephen","year":"2017","unstructured":"Stephen AM, Champ MM-J, Cloran SJ, Fleith M, Van Lieshout L, Mejborn H, et al. Dietary fibre in Europe: current state of knowledge on definitions, sources, recommendations, intakes and relationships to health. Nutr Res Rev. 2017. https:\/\/doi.org\/10.1017\/S095442241700004X.","journal-title":"Nutr Res Rev"},{"issue":"1","key":"538_CR49","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s13311-017-0581-4","volume":"15","author":"P Riccio","year":"2018","unstructured":"Riccio P, Rossano R. Diet, gut microbiota, and vitamins D+ A in multiple sclerosis. Neurotherapeutics. 2018;15(1):75\u201391. https:\/\/doi.org\/10.1007\/s13311-017-0581-4.","journal-title":"Neurotherapeutics"},{"issue":"7","key":"538_CR50","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1097\/cm9.0000000000000696","volume":"133","author":"PX Wang","year":"2020","unstructured":"Wang PX, Deng XR, Zhang CH, Yuan HJ. Gut microbiota and metabolic syndrome. Chin Med J (Engl). 2020;133(7):808\u201316. https:\/\/doi.org\/10.1097\/cm9.0000000000000696.","journal-title":"Chin Med J (Engl)"},{"issue":"2","key":"538_CR51","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1111\/imm.12903","volume":"154","author":"N Dopkins","year":"2018","unstructured":"Dopkins N, Nagarkatti PS, Nagarkatti M. The role of gut microbiome and associated metabolome in the regulation of neuroinflammation in multiple sclerosis and its implications in attenuating chronic inflammation in other inflammatory and autoimmune disorders. Immunology. 2018;154(2):178\u201385. https:\/\/doi.org\/10.1111\/imm.12903.","journal-title":"Immunology"},{"key":"538_CR52","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241914756","author":"SK Yadav","year":"2023","unstructured":"Yadav SK, Ito K, Dhib-Jalbut S. Interaction of the gut microbiome and immunity in multiple sclerosis: impact of diet and immune therapy. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms241914756.","journal-title":"Int J Mol Sci"},{"key":"538_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2023.104958","volume":"79","author":"S Manche","year":"2023","unstructured":"Manche S, Probst Y. Exploring the socio-ecological factors impacting lifestyle management of multiple sclerosis: a scoping review. Multiple Sclerosis and Related Disorders. 2023;79: 104958. https:\/\/doi.org\/10.1016\/j.msard.2023.104958.","journal-title":"Multiple Sclerosis and Related Disorders"},{"issue":"4","key":"538_CR54","doi-asserted-by":"publisher","first-page":"175","DOI":"10.7224\/1537-2073.2021-052","volume":"24","author":"SL Silveira","year":"2022","unstructured":"Silveira SL, Richardson EV, Motl RW. Desired resources for changing diet among persons with multiple sclerosis: qualitative inquiry informing future dietary interventions. International Journal of MS Care. 2022;24(4):175\u201383. https:\/\/doi.org\/10.7224\/1537-2073.2021-052.","journal-title":"International Journal of MS Care"},{"issue":"5","key":"538_CR55","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.jneb.2019.12.007","volume":"52","author":"S Baker","year":"2020","unstructured":"Baker S, Auld G, Ammerman A, Lohse B, Serrano E, Wardlaw MK. Identification of a framework for best practices in nutrition education for low-income audiences. J Nutr Educ Behav. 2020;52(5):546\u201352. https:\/\/doi.org\/10.1016\/j.jneb.2019.12.007.","journal-title":"J Nutr Educ Behav"},{"issue":"1","key":"538_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12966-023-01424-2","volume":"20","author":"AL Deslippe","year":"2023","unstructured":"Deslippe AL, Soanes A, Bouchaud CC, Beckenstein H, Slim M, Plourde H, et al. Barriers and facilitators to diet, physical activity and lifestyle behavior intervention adherence: a qualitative systematic review of the literature. Int J Behav Nutr Phys Act. 2023;20(1):1\u201325. https:\/\/doi.org\/10.1186\/s12966-023-01424-2.","journal-title":"Int J Behav Nutr Phys Act"},{"issue":"6","key":"538_CR57","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1080\/09638288.2018.1510550","volume":"42","author":"E Barnard","year":"2020","unstructured":"Barnard E, Brown CR, Weiland TJ, Jelinek GA, Marck CH. Understanding barriers, enablers, and long-term adherence to a health behavior intervention in people with multiple sclerosis. Disabil Rehabil. 2020;42(6):822\u201332. https:\/\/doi.org\/10.1080\/09638288.2018.1510550.","journal-title":"Disabil Rehabil"},{"issue":"1","key":"538_CR58","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s41687-022-00496-1","volume":"6","author":"E Faraclas","year":"2022","unstructured":"Faraclas E, Merlo A, Lynn J, Lau JD. Perceived facilitators, needs, and barriers to health related quality of life in people with multiple sclerosis: a qualitative investigation. Journal of Patient-Reported Outcomes. 2022;6(1):89. https:\/\/doi.org\/10.1186\/s41687-022-00496-1.","journal-title":"Journal of Patient-Reported Outcomes"},{"issue":"5","key":"538_CR59","doi-asserted-by":"publisher","first-page":"235","DOI":"10.7224\/1537-2073.2021-051","volume":"24","author":"C Dean","year":"2022","unstructured":"Dean C, Parks S, Titcomb TJ, Arthofer A, Meirick P, Grogan N, et al. Facilitators of and barriers to adherence to dietary interventions perceived by women with multiple sclerosis and their support persons. International journal of MS care. 2022;24(5):235\u201341. https:\/\/doi.org\/10.7224\/1537-2073.2021-051.","journal-title":"International journal of MS care"},{"key":"538_CR60","doi-asserted-by":"publisher","first-page":"124","DOI":"10.5116\/ijme.6271.3aa2","volume":"13","author":"C Carter","year":"2022","unstructured":"Carter C, Harnett JE, Krass I, Gelissen IC. A review of primary healthcare practitioners\u2019 views about nutrition: implications for medical education. Int J Med Educ. 2022;13:124\u201337. https:\/\/doi.org\/10.5116\/ijme.6271.3aa2.","journal-title":"Int J Med Educ"},{"issue":"12","key":"538_CR61","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1001\/jama.2017.10434","volume":"318","author":"S Kahan","year":"2017","unstructured":"Kahan S, Manson JE. Nutrition counseling in clinical practice: how clinicians can do better. JAMA. 2017;318(12):1101\u20132. https:\/\/doi.org\/10.1001\/jama.2017.10434.","journal-title":"JAMA"}],"container-title":["Current Nutrition Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13668-024-00538-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13668-024-00538-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13668-024-00538-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,29]],"date-time":"2024-05-29T00:05:48Z","timestamp":1716941148000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13668-024-00538-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,27]]},"references-count":61,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,6]]}},"alternative-id":["538"],"URL":"https:\/\/doi.org\/10.1007\/s13668-024-00538-8","relation":{},"ISSN":["2161-3311"],"issn-type":[{"value":"2161-3311","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,27]]},"assertion":[{"value":"2 April 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Yasmine Probst is a person living with MS and is supported by a fellowship funded by MS Australia. She has also received honoraria from other MS organizations. Shoroog Allogmanny has no competing interests to declare that are relevant to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}